C07D 411/00
Heterocyclic compounds containing two or more hetero rings, at least one ring
Official title: Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
C07D411/00 (Heterocyclic compounds containing two or more hetero rings, at least one ring) appears on 488 US grants and 471 published applications in this corpus.
Search patents in C07D- Granted patents
- 488
- Published applications
- 471
- Assignees
- 298
- Inventors
- 1,894
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 4 | 0 |
| 1988 | 5 | 0 |
| 1989 | 3 | 0 |
| 1990 | 9 | 0 |
| 1991 | 8 | 0 |
| 1992 | 13 | 0 |
| 1993 | 14 | 0 |
| 1994 | 11 | 0 |
| 1995 | 11 | 0 |
| 1996 | 13 | 0 |
| 1997 | 14 | 0 |
| 1998 | 19 | 0 |
| 1999 | 13 | 0 |
| 2000 | 14 | 0 |
| 2001 | 14 | 2 |
| 2002 | 10 | 12 |
| 2003 | 11 | 19 |
| 2004 | 15 | 20 |
| 2005 | 8 | 19 |
| 2006 | 13 | 25 |
| 2007 | 6 | 17 |
| 2008 | 7 | 6 |
| 2009 | 13 | 21 |
| 2010 | 6 | 23 |
| 2011 | 13 | 22 |
| 2012 | 15 | 11 |
| 2013 | 11 | 20 |
| 2014 | 15 | 19 |
| 2015 | 23 | 18 |
| 2016 | 6 | 22 |
| 2017 | 23 | 23 |
| 2018 | 14 | 12 |
| 2019 | 16 | 22 |
| 2020 | 17 | 25 |
| 2021 | 15 | 16 |
| 2022 | 12 | 22 |
| 2023 | 9 | 20 |
| 2024 | 10 | 25 |
| 2025 | 12 | 14 |
| 2026 | 11 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Non-aqueous electrolyte and battery6 Oct 2026US 12,756,014 B2Shenzhen Capchem Technology Co., Ltd.
- Compounds useful as immunomodulators25 Aug 2026US 12,715,856 B2Bristol-Myers Squibb Company
- Inhibition of glial cell activation7 Jul 2026US 12,673,957 B2Lapko Inc
- Organic compound, and electronic element and electronic device thereof16 Jun 2026US 12,655,134 B2Shaanxi Lighte Optoelectronics Material Co., Ltd.
- Synthesis of small molecules inspired by phomoxanthone A9 Jun 2026US 12,649,725 B2Worcester Polytechnic Institute
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Structure-based optimization of s6k2 inhibitor cd02 to target melanoma10 Sep 2026US 2026/0263417 A1The Trustees of the University of Pennsylvania
- Highly atom economical process for synthesis of novel co-initiator for photo-induced radical polymerisation20 Aug 2026US 2026/0242348 A1SHIV NADAR (Institution of Eminence Deemed To Be University)
- Therapeutic alkaloid compounds13 Aug 2026US 2026/0234131 A1Sensorium Therapeutics, Inc.
- Prodrugs of mdma, mda, and derivatives thereof6 Aug 2026US 2026/0226017 A1EmpathBio, Inc.
Most cited
By later US patents
- 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties128US 5,047,407 AIAF BioChem International, Inc. · 1991
- Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds108US 5,210,085 AEmory University · 1993
- 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections104US 5,041,449 AIAF BioChem International, Inc. · 1991
- Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions103US 5,614,548 AWake Forest University · 1997
- Method and compositions for the synthesis of BCH-189 and related compounds92US 5,204,466 AEmory University · 1993